Regulatory Data and Market Protection Under the New EU Pharma Package

One of the most closely watched parts of the EU pharmaceutical reform is how long innovators are protected from generic and biosimilar competition. Published legal analyses describe a baseline of eight years of data protection, with market protection that can be extended in defined circumstances.

The reported structure

According to law firm summaries of the final compromise, the new framework provides eight years of regulatory data protection from authorisation, followed by one year of market protection. An additional year of market protection can be earned in certain situations, including where the product meets an unmet medical need or where specified comparative trial and early EU application criteria are fulfilled.

The exact conditions are set out in the legal texts and should be read there before being relied on.

Transferable exclusivity voucher

For priority antimicrobials, the reform introduces a transferable data exclusivity voucher giving one additional year of data protection. Published analyses refer to a ceiling linked to annual gross sales of EUR 490 million, so that products with very high revenues cannot use it.

When the new periods apply

Analyses of the transition indicate that new protection periods apply to reference products whose applications are submitted around 24 months after entry into force, which points to late 2028. Earlier applications continue under current rules.

Planning implications

  • Portfolio timing. Submission dates now influence which protection regime applies.
  • Generic and biosimilar entry. Competitors will need to understand which regime governs each reference product.
  • Conditions are strategic. Qualifying for an extra year may influence trial design and the sequence of EU filings.

How PQRA helps

PQRA helps innovators and generic companies model protection scenarios, align development and filing plans with the transition rules, and prepare for launch planning and loss of exclusivity.

Contact PQRA to discuss your situation

CATEGORIES:

Uncategorized

Tags:

No responses yet

Αφήστε μια απάντηση

Η ηλ. διεύθυνση σας δεν δημοσιεύεται. Τα υποχρεωτικά πεδία σημειώνονται με *